UK approved Johnson & Johnson's oral psoriasis treatment, and Amundi increased its holdings in J&J shares.

The entities involved

• Johnson & Johnson →

  U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

  • Coca-Cola and Johnson & Johnson announced dividend raises, while SmartAsset continues to assist users with retirement planning.Sun 20:51
  • MarketBeat listed Johnson & Johnson, AbbVie, Pfizer, Merck KGaA, Eli Lilly, Gilead Sciences, and Novartis as stocks to watch.Sat 22:36
• Amundi →

  French subsidiary jointly created by Crédit Agricole and Société Générale

  • Amundi increased its investment stake in Tesla shares on October 6, 2026.Sun 13:36
  • Amundi grew its stake in Cameco on October 25, 2026.Sun 10:09

Related events

• The UK approved Johnson & Johnson's oral treatment for psoriasis.Sat 18:36
• AbbVie, Johnson & Johnson, Bristol-Myers Squibb, and Amgen are innovating targeted, cost-effective therapies for psoriatic arthritis.Jun 8
• Johnson & Johnson joins the USMN initiative.Thu 14:49